Gainers
- Nexalin Technology (NASDAQ:NXL) shares rose 55.8% to $1.62 during Tuesday’s after-market session. The market value of their outstanding shares is at $12.0 million.
- Dynatronics (NASDAQ:DYNT) stock rose 14.74% to $0.4. The company’s market cap stands at $2.1 million.
- Oncology Institute (NASDAQ:TOI) shares moved upwards by 10.8% to $0.45. The market value of their outstanding shares is at $33.5 million.
- SAB Biotherapeutics (NASDAQ:SABS) stock rose 8.94% to $2.8. The market value of their outstanding shares is at $25.8 million.
- Bone Biologics (NASDAQ:BBLG) shares moved upwards by 8.04% to $1.61. The company’s market cap stands at $1.7 million.
- Virpax Pharmaceuticals (NASDAQ:VRPX) shares increased by 7.17% to $0.61. The market value of their outstanding shares is at $1.6 million.
Losers
- Biolase (NASDAQ:BIOL) stock fell 9.9% to $0.12 during Tuesday’s after-market session. The company’s market cap stands at $3.8 million.
- Evaxion Biotech (NASDAQ:EVAX) stock declined by 9.53% to $2.47. The market value of their outstanding shares is at $13.3 million.
- Soligenix (NASDAQ:SNGX) stock decreased by 8.5% to $3.88. The market value of their outstanding shares is at $3.8 million.
- Redhill Biopharma (NASDAQ:RDHL) stock decreased by 8.19% to $0.36. The company’s market cap stands at $11.4 million.
- Sunshine Biopharma (NASDAQ:SBFM) stock decreased by 7.86% to $0.36. The company’s market cap stands at $6.8 million.
- Ensysce Biosciences (NASDAQ:ENSC) shares fell 7.82% to $0.52. The company’s market cap stands at $3.9 million.
See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
